Ignite Creation Date:
2024-05-06 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 12:53 PM
Study NCT ID:
NCT03657719
Status:
COMPLETED
Last Update Posted:
2019-01-04
First Post:
2018-08-27
Brief Title:
A Study to Evaluate the Safety and EfficacyImmunogenicity of GC3114 in Elderly Healthy Subjects
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp
Study Overview
Official Title:
Open-labeledPart 1 Single-groupPart 2 RandomizedPart 2 Double-blindPart 2 Active-controlledPart 2 Pharse II Clinical Trial to Evaluate Safety and EfficacyImmunogenicity of GC3114 in Elderly Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2019-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Elderly healthy subjects will be once administered GC3114AHigh-dose Quadrivalent influenza vaccine or GCFLU Quadrivalent Pre-filled syringe inj
Detailed Description:
Elderly healthy subjects will be once administered GC3114AHigh-dose Quadrivalent influenza vaccine or GCFLU Quadrivalent Pre-filled syringe inj
Safety and immunological efficacy will be evaluated
Safety and immunological efficacy will be evaluated
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None